Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Tractography Analysis of 5 White Matter Bundles and Their Clinical and Cognitive Correlates in Early-Course Schizophrenia.
Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
Successful desensitization to natalizumab in a skin test--positive patient: a case report.
Month of Birth Does Not Seem to Interfere with the Development of Multiple Sclerosis Later in Life in Brazilian Patients.
[The comparative study of efficacy and tolerability of intramuscular introduction of beta-interferon-1a in adults and adolescents with remitting multiple sclerosis.]
Phenytoin protects central axons in experimental autoimmune encephalomyelitis.
New data at AAN to confirm efficacy of Novartis' Gilenya® across four key measures of MS disease activity, including brain volume loss
Incidence of Mood or Anxiety Disorders in Children of Parents with Multiple Sclerosis.
Elevated Expression of the Cerebrospinal Fluid Disease Markers Chromogranin A and Clusterin in Astrocytes of Multiple Sclerosis White Matter Lesions.
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Ginseng in the Treatment of Fatigue in Multiple Sclerosis: A Randomized Placebo-Controlled Double-Blind Pilot Study.
Fatigue and fatigability in neurologic illnesses: Proposal for a unified taxonomy.
Symptom overlap in anxiety and multiple sclerosis.
The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis.
PLEGRIDY™ (peginterferon beta-1a) two-year data confirm maintenance of efficacy and safety in multiple sclerosis patients
Ocular Findings in Alemtuzumab (Campath-1H)-induced Thyroid Eye Disease.
The effect of supported standing in adults with upper motor neurone disorders: a systematic review.
Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis.
Oral Agent Outcomes
Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1.
Ampyra 10mg beats 5mg, but weak overall results net neutral for ACOR
Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.
Effects of Dalfampridine Extended-Release Tablets on 6-Minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-Blind, Placebo-Controlled Trial.
Epidermal pigmentation in the human lineage is an adaptation to ultraviolet radiation.

Pages